Evidence map›Paper›PMID 40662736›Full record

ArticleMicrobiology spectrum2025

Nourseothricin as a novel therapeutic agent against

Izumo Kanesaka, Said Abdellati, Zina Gestels, Thibaut Vanbaelen, Irith De Baetselier, Tessa de Block, Sheeba Santhini Manoharan-Basil, Chris Kenyon

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Izumo KanesakaDepartment of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.ORCID 0000-0002-5918-2297
Said AbdellatiDepartment of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Zina GestelsDepartment of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Thibaut VanbaelenDepartment of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Irith De BaetselierDepartment of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.ORCID 0000-0002-1804-252X
Tessa de BlockDepartment of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Sheeba Santhini Manoharan-BasilDepartment of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.ORCID 0000-0001-8421-5137
Chris KenyonDepartment of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.ORCID 0000-0002-2557-8998

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsGonorrheaNeisseria gonorrhoeaeAnimalsCeftriaxoneDisease Models, AnimalDrug Resistance, Multiple, BacterialHumansLarvaMicrobial Sensitivity TestsMothsPilot ProjectsAnti-Bacterial AgentsCeftriaxoneGalleria mellonellagonorrheaNeisseria gonorrhoeaenourseothricinstreptothricin F

Identifiers

PMID40662736
PMCPMC12323372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.